von Borstel RW[au] - Search Results

Year	Number of Results
1978	1
1983	1
1984	1
1986	2
1987	1
2001	2
2003	1
2005	1
2006	1
2016	1
2017	1
2018	1
2022	0

1

Prompt treatment with uridine triacetate improves survival and reduces toxicity due to fluorouracil and capecitabine overdose or dihydropyrimidine dehydrogenase deficiency.

Garcia RAG, Saydoff JA, Bamat MK, von Borstel RW. Garcia RAG, et al. Among authors: von borstel rw. Toxicol Appl Pharmacol. 2018 Aug 15;353:67-73. doi: 10.1016/j.taap.2018.06.012. Epub 2018 Jun 13. Toxicol Appl Pharmacol. 2018. PMID: 29908244

2

Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.

Ma WW, Saif MW, El-Rayes BF, Fakih MG, Cartwright TH, Posey JA, King TR, von Borstel RW, Bamat MK. Ma WW, et al. Among authors: von borstel rw. Cancer. 2017 Jan 1;123(2):345-356. doi: 10.1002/cncr.30321. Epub 2016 Sep 13. Cancer. 2017. PMID: 27622829 Free PMC article.

3

Genetic variants in an acetylcholine receptor from Drosophila melanogaster.

Hall LM, Von Borstel RW, Osmond BC, Hoeltzli SD, Hudson TH. Hall LM, et al. Among authors: von borstel rw. FEBS Lett. 1978 Nov 15;95(2):243-8. doi: 10.1016/0014-5793(78)81003-5. FEBS Lett. 1978. PMID: 102532 Free article. No abstract available.

4

Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease.

Saydoff JA, Garcia RA, Browne SE, Liu L, Sheng J, Brenneman D, Hu Z, Cardin S, Gonzalez A, von Borstel RW, Gregorio J, Burr H, Beal MF. Saydoff JA, et al. Among authors: von borstel rw. Neurobiol Dis. 2006 Dec;24(3):455-65. doi: 10.1016/j.nbd.2006.08.011. Epub 2006 Sep 29. Neurobiol Dis. 2006. PMID: 17011205

5

Chronic caffeine consumption potentiates the hypotensive action of circulating adenosine.

von Borstel RW, Wurtman RJ, Conlay LA. von Borstel RW, et al. Life Sci. 1983 Mar 7;32(10):1151-8. doi: 10.1016/0024-3205(83)90121-2. Life Sci. 1983. PMID: 6827895

6

Adenosine potentiates sympathomimetic effects of nicotinic agonists in vivo.

von Borstel RW, Evoniuk GE, Wurtman RJ. von Borstel RW, et al. J Pharmacol Exp Ther. 1986 Feb;236(2):344-9. J Pharmacol Exp Ther. 1986. PMID: 3003340

7

Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.

Evoniuk G, von Borstel RW, Wurtman RJ. Evoniuk G, et al. Among authors: von borstel rw. J Pharmacol Exp Ther. 1987 Feb;240(2):428-32. J Pharmacol Exp Ther. 1987. PMID: 3806407

8

Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine.

Garcia RA, Liu L, Hu Z, Gonzalez A, von Borstel RW, Saydoff JA. Garcia RA, et al. Among authors: von borstel rw. Brain Res. 2005 Dec 20;1066(1-2):164-71. doi: 10.1016/j.brainres.2005.10.056. Epub 2005 Dec 5. Brain Res. 2005. PMID: 16330000

9

A rapid assay for mitochondrial DNA damage and respiratory chain inhibition in the yeast Saccharomyces cerevisiae.

Barclay BJ, DeHaan CL, Hennig UG, Iavorovska O, von Borstel RW, von Borstel RC. Barclay BJ, et al. Among authors: von borstel rw. Environ Mol Mutagen. 2001;38(2-3):153-8. doi: 10.1002/em.1066. Environ Mol Mutagen. 2001. PMID: 11746749

10

Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease.

Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, von Borstel RW. Saydoff JA, et al. Among authors: von borstel rw. Brain Res. 2003 Dec 19;994(1):44-54. doi: 10.1016/j.brainres.2003.09.049. Brain Res. 2003. PMID: 14642447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results